Sonja Zweegman

34PUBLICATIONS
193CO-AUTHORS
Tumour immunologyNanomedicineMedical bacteriologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 09, 2026
The rapidly evolving BCMA landscape in multiple myeloma.

|Jun 03, 2026
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.

|May 05, 2026
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE.

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Sep 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman

Pageof 6

Frequent Collaborators

10 joint publications

Pieter Sonneveld

7 joint publications

Niels W C J van de Donk

6 joint publications

Tuna Mutis

6 joint publications

Mark-David Levin